TY - JOUR
T1 - Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement
T2 - Hematological, nephrological, and otological studies of heterozygous KO mice
AU - Matsushita, Tadashi
AU - Hayashi, Hideo
AU - Kunishima, Shinji
AU - Hayashi, Mutsuharu
AU - Ikejiri, Makoto
AU - Takeshita, Kyosuke
AU - Yuzawa, Yukio
AU - Adachi, Tatsuya
AU - Hirashima, Kanji
AU - Sone, Michihiko
AU - Yamamoto, Koji
AU - Takagi, Akira
AU - Katsumi, Akira
AU - Kawai, Kumi
AU - Nezu, Tomoyo
AU - Takahashi, Masahide
AU - Nakashima, Tsutomu
AU - Naoe, Tomoki
AU - Kojima, Tetsuhito
AU - Saito, Hidehiko
N1 - Funding Information:
This work is partly supported by Grants-in-Aid No. 16390283 (H.S.) and No. 16590971 (S.K.) from Japan Society for the Promotion of Science.
PY - 2004/12/24
Y1 - 2004/12/24
N2 - Among three different isoforms of non-muscle myosin heavy chains (NMMHCs), only NMMHCA is associated with inherited human disease, called MYH9 disorders, characterized by macrothrombocytopenia and characteristic granulocyte inclusions. Here targeted gene disruption was performed to understand fundamental as well as pathological role of the gene for NMMHCA, MYH9. Heterozygous intercrosses yielded no homozygous animals among 552 births, suggesting that MYH9 expression is required for embryonic development. In contrast, MYH9+/- mice were viable and fertile without gross anatomical, hematological, and nephrological abnormalities. Immunofluorescence analysis also showed the normal cytoplasmic distribution of NMMHCA. We further measured the auditory brainstem response and found two of six MYH9+/- mice had hearing losses, whereas the remaining four were comparable to wild-type mice. Such observation may parallel the diverse expression of Alport's manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs.
AB - Among three different isoforms of non-muscle myosin heavy chains (NMMHCs), only NMMHCA is associated with inherited human disease, called MYH9 disorders, characterized by macrothrombocytopenia and characteristic granulocyte inclusions. Here targeted gene disruption was performed to understand fundamental as well as pathological role of the gene for NMMHCA, MYH9. Heterozygous intercrosses yielded no homozygous animals among 552 births, suggesting that MYH9 expression is required for embryonic development. In contrast, MYH9+/- mice were viable and fertile without gross anatomical, hematological, and nephrological abnormalities. Immunofluorescence analysis also showed the normal cytoplasmic distribution of NMMHCA. We further measured the auditory brainstem response and found two of six MYH9+/- mice had hearing losses, whereas the remaining four were comparable to wild-type mice. Such observation may parallel the diverse expression of Alport's manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs.
UR - http://www.scopus.com/inward/record.url?scp=8844261172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8844261172&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2004.10.147
DO - 10.1016/j.bbrc.2004.10.147
M3 - Article
C2 - 15555549
AN - SCOPUS:8844261172
SN - 0006-291X
VL - 325
SP - 1163
EP - 1171
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 4
ER -